BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20561301)

  • 1. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Clark DA; Leong HN; Heslop HE; Brenner MK; Carrum G
    Bone Marrow Transplant; 2007 Sep; 40(6):563-6. PubMed ID: 17637686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute human herpesvirus 6 (HHV-6) infections: when and how to treat?].
    Agut H
    Pathol Biol (Paris); 2011 Apr; 59(2):108-12. PubMed ID: 20832191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
    Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
    Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human herpesvirus-6 and -7 in pediatric stem cell transplantation.
    Savolainen H; Lautenschlager I; Piiparinen H; Saarinen-Pihkala U; Hovi L; Vettenranta K
    Pediatr Blood Cancer; 2005 Nov; 45(6):820-5. PubMed ID: 15700258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation.
    Caïola D; Karras A; Flandre P; Boutolleau D; Scieux C; Agut H; Legendre C; Gautheret-Dejean A
    J Med Virol; 2012 Mar; 84(3):450-6. PubMed ID: 22246831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
    Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
    Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation.
    Maeda Y; Teshima T; Yamada M; Shinagawa K; Nakao S; Ohno Y; Kojima K; Hara M; Nagafuji K; Hayashi S; Fukuda S; Sawada H; Matsue K; Takenaka K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Br J Haematol; 1999 Apr; 105(1):295-302. PubMed ID: 10233397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
    Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
    Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients.
    Wang FZ; Larsson K; Linde A; Ljungman P
    Bone Marrow Transplant; 2002 Oct; 30(8):521-6. PubMed ID: 12379892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
    Pöhlmann C; Schetelig J; Reuner U; Bornhäuser M; Illmer T; Kiani A; Ehninger G; Jacobs E; Rohayem J
    Clin Infect Dis; 2007 Jun; 44(12):e118-20. PubMed ID: 17516391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
    Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
    Br J Haematol; 2000 Dec; 111(3):774-81. PubMed ID: 11122137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomally integrated human herpesvirus-6 in transplant recipients.
    Lee SO; Brown RA; Razonable RR
    Transpl Infect Dis; 2012 Aug; 14(4):346-54. PubMed ID: 22321264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant].
    Najima Y; Ohashi K; Ando M; Koshida A; Yamashita T; Akiyama H; Sakamaki H
    Rinsho Ketsueki; 2008 Jan; 49(1):40-5. PubMed ID: 18277595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
    Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human herpes virus 6 infection in renal transplant recipient--case report].
    Deborska-Materkowska D; Sadowska A; Matłosz B; Zegarska J; Durlik M
    Przegl Epidemiol; 2006; 60(1):141-6. PubMed ID: 16758753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.